While studies in experimental AD murine models have reported increased corticosterone levels [29], it is unclear whether changes in systemic insulin action and glucocorticoid exposure occur during the pre-symptomatic stage or around the time of observable clinical signs and subsequent diagnosis. Here, INS is linked to Alzheimer disease.